Comparing Octreotide vs Methylphenidate
Octreotide | Methylphenidate |
|
---|
Octreotide | Methylphenidate |
|
|||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Prescription only
Prescribed for Carcinoid Tumor, Acromegaly, Diarrhea, Diabetes - Type 1, Dumping Syndrome, Gastrinoma, Glucagonoma, Insulinoma, Pituitary Adenoma, Postural Orthostatic Tachycardia Syndrome, Small... View more |
Prescription only
Methylphenidate improves symptoms of ADHD but carries with it a risk of dependence and side effects such as insomnia are common. To avoid insomnia the last dose should be administered before 6 pm... View more |
Related suggestions Postural Orthostatic Tachycardia Syndrome
Popular comparisons
|
|||||||||||||||
More about Octreotide | More about Methylphenidate | ||||||||||||||||
Ratings & Reviews | |||||||||||||||||
Octreotide has an average rating of 7.6 out of 10 from a total of 17 ratings on Drugs.com. 69% of reviewers reported a positive effect, while 8% reported a negative effect. |
Methylphenidate has an average rating of 7.2 out of 10 from a total of 1065 ratings on Drugs.com. 61% of reviewers reported a positive effect, while 17% reported a negative effect. |
||||||||||||||||
Drug Class | |||||||||||||||||
Side Effects | |||||||||||||||||
See also: octreotide side effects in more detail. |
See also: methylphenidate side effects in more detail. |
||||||||||||||||
Generic Availability | |||||||||||||||||
Lower cost generic |
Lower cost generic |
||||||||||||||||
Pricing and Coupons * Prices are without insurance | |||||||||||||||||
View all octreotide prices |
View all methylphenidate prices |
||||||||||||||||
Dosage Form(s) Available | |||||||||||||||||
|
|
||||||||||||||||
Brand Names | |||||||||||||||||
Bynfezia Pen, Mycapssa, Sandostatin, Sandostatin LAR Depot | Adhansia XR, Aptensio XR, Concerta, Cotempla XR-ODT, Daytrana, Jornay PM, Metadate CD, Methylin, Methylin ER, QuilliChew ER, Quillivant XR, Relexxii, Ritalin, Ritalin LA View more | ||||||||||||||||
Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | |||||||||||||||||
1.5 hours |
4 hours |
||||||||||||||||
CSA Schedule ** View glossary of terms | |||||||||||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
High potential for abuse
Has a high potential for abuse. Has a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions. Abuse may lead to severe psychological or physical dependence. |
||||||||||||||||
Pregnancy Category | |||||||||||||||||
Category B
No proven risk in humans
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||||||||||
Drug Interactions | |||||||||||||||||
A total of 155 drugs are known to interact with octreotide:
|
A total of 198 drugs are known to interact with methylphenidate:
|
||||||||||||||||
Alcohol/Food/Lifestyle Interactions | |||||||||||||||||
|
|
||||||||||||||||
Disease Interactions | |||||||||||||||||
First Approval Date | |||||||||||||||||
June 26, 2020 |
December 05, 1955 |
||||||||||||||||
WADA Class View World Anti-Doping Agency classifications. | |||||||||||||||||
N/A |
|||||||||||||||||
More Information | |||||||||||||||||
Patient resources | |||||||||||||||||
Professional Resources | |||||||||||||||||
Related Treatment Guide | |||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.